1. Home
  2. KARO vs AGIO Comparison

KARO vs AGIO Comparison

Compare KARO & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KARO
  • AGIO
  • Stock Information
  • Founded
  • KARO 2001
  • AGIO 2007
  • Country
  • KARO Singapore
  • AGIO United States
  • Employees
  • KARO N/A
  • AGIO N/A
  • Industry
  • KARO Computer Software: Prepackaged Software
  • AGIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • KARO Technology
  • AGIO Health Care
  • Exchange
  • KARO Nasdaq
  • AGIO Nasdaq
  • Market Cap
  • KARO 1.7B
  • AGIO 1.4B
  • IPO Year
  • KARO 2021
  • AGIO 2013
  • Fundamental
  • Price
  • KARO $50.01
  • AGIO $40.46
  • Analyst Decision
  • KARO Strong Buy
  • AGIO Buy
  • Analyst Count
  • KARO 3
  • AGIO 6
  • Target Price
  • KARO $57.00
  • AGIO $58.60
  • AVG Volume (30 Days)
  • KARO 64.9K
  • AGIO 641.2K
  • Earning Date
  • KARO 07-22-2025
  • AGIO 07-31-2025
  • Dividend Yield
  • KARO 2.22%
  • AGIO N/A
  • EPS Growth
  • KARO 24.98
  • AGIO N/A
  • EPS
  • KARO 1.60
  • AGIO 11.45
  • Revenue
  • KARO $245,745,961.00
  • AGIO $37,035,000.00
  • Revenue This Year
  • KARO $20.68
  • AGIO $22.30
  • Revenue Next Year
  • KARO $15.64
  • AGIO $219.19
  • P/E Ratio
  • KARO $31.21
  • AGIO $3.50
  • Revenue Growth
  • KARO 8.61
  • AGIO 25.96
  • 52 Week Low
  • KARO $28.04
  • AGIO $23.42
  • 52 Week High
  • KARO $63.36
  • AGIO $62.58
  • Technical
  • Relative Strength Index (RSI)
  • KARO 51.13
  • AGIO 74.69
  • Support Level
  • KARO $49.01
  • AGIO $34.60
  • Resistance Level
  • KARO $51.99
  • AGIO $40.95
  • Average True Range (ATR)
  • KARO 1.82
  • AGIO 1.44
  • MACD
  • KARO 0.16
  • AGIO 0.35
  • Stochastic Oscillator
  • KARO 64.31
  • AGIO 97.34

About KARO Karooooo Ltd.

Karooooo Ltd is a provider of real-time mobility data analytics solutions for smart transportation. It offers a comprehensive, cloud-based smart mobility platform for connected vehicles and other assets. The company's software-as-a-service platform provides customers with differentiated insights and analytics to optimize business and workforce, increase efficiency and decrease costs, improve safety, monitor environmental impact, assist with regularity compliance, and manage risk. The segments of the group are Cartrack; Carzuka; and Karooooo Logistics, of which key revenue is derived from the Cartrack segment.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.

Share on Social Networks: